Evidence map›Paper›PMID 20726290›Full record

GuidelineJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2010

Best practice guide for the treatment of nightmare disorder in adults.

R Nisha Aurora, Rochelle S Zak, Sanford H Auerbach, Kenneth R Casey, Susmita Chowdhuri, Anoop Karippot, Rama K Maganti, Kannan Ramar, David A Kristo, Sabin R Bista and 4 more

2 registry-linked trialsAbstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 90 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 6 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02382848 nacompletednot on this mapstarted 2015, after this paper: background citation

Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD

TypeinterventionalSponsorMilton S. Hershey Medical CenterRan2015 to 2018Enrolled9ConditionsStress Disorders, Post-Traumatic, Bulimia NervosaArmsPrazosin, Placebo
NCT04198142 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Treatment of Nightmares in Psychiatric Inpatients With Imagery Rehearsal Therapy: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of ZurichRan2019 to 2020Enrolled60ConditionsNightmare, Psychiatric DisorderArmsImagery Rehearsal Therapy, Treatment as Usual with dream diaries
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 6 syntheses or guidelines pooled it, 328 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2018
    Guideline
  4. Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2017
    Pooled it
  5. Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2015
    Pooled it
  6. Pooled it
  7. Transdiagnostic cognitive behavioral therapy for nightmares and parasomnias.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Trial
  8. A randomized sham-controlled clinical trial of a novel wearable intervention for trauma-related nightmares in military veterans.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

R Nisha AuroraMount Sinai Medical Center, New York, NY, USA.
Rochelle S Zak
Sanford H Auerbach
Kenneth R Casey
Susmita Chowdhuri
Anoop Karippot
Rama K Maganti
Kannan Ramar
David A Kristo
Sabin R Bista
Carin I Lamm
Timothy I Morgenthaler
Standards of Practice Committee
American Academy of Sleep Medicine
Mayo Clinic in Arizona · USBarrow Neurological Institute · USBoston University · USColumbia University Irving Medical Center · USJohn D. Dingell VA Medical Center · USMount Sinai Medical Center · USUniversity of Louisville · USUniversity of Nebraska Medical Center · USUniversity of Pittsburgh · USVeterans Health Administration · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prazosin is recommended for treatment of Posttraumatic Stress Disorder (PTSD)-associated nightmares. Level A. Image Rehearsal Therapy (IRT) is recommended for treatment of nightmare disorder. Level A. Systematic Desensitization and Progressive Deep Muscle Relaxation training are suggested for treatment of idiopathic nightmares. Level B. Venlafaxine is not suggested for treatment of PTSD-associated nightmares. Level B. Clonidine may be considered for treatment of PTSD-associated nightmares. Level C. The following medications may be considered for treatment of PTSD-associated nightmares, but the data are low grade and sparse: trazodone, atypical antipsychotic medications, topiramate, low dose cortisol, fluvoxamine, triazolam and nitrazepam, phenelzine, gabapentin, cyproheptadine, and tricyclic antidepressants. Nefazodone is not recommended as first line therapy for nightmare disorder because of the increased risk of hepatotoxicity. Level C. The following behavioral therapies may be considered for treatment of PTSD-associated nightmares based on low-grade evidence: Exposure, Relaxation, and Rescripting Therapy (ERRT); Sleep Dynamic Therapy; Hypnosis; Eye-Movement Desensitization and Reprocessing (EMDR); and the Testimony Method. Level C. The following behavioral therapies may be considered for treatment of nightmare disorder based on low-grade evidence: Lucid Dreaming Therapy and Self-Exposure Therapy. Level C No recommendation is made regarding clonazepam and individual psychotherapy because of sparse data.

Indexed as

AdultClonidineCognitive Behavioral TherapyDreamsEvidence-Based MedicineEye Movement Desensitization ReprocessingHumansHypnosisNorepinephrinePrazosinPsychotropic DrugsRandomized Controlled Trials as TopicRelaxation TherapyStress Disorders, Post-TraumaticClonidineNorepinephrinePrazosinPsychotropic Drugs

Identifiers

PMID20726290
PMCPMC2919672
OpenAlexW2119624339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.